Summary
Neurodegenerative processes are generally characterized by the long-lasting course of neuronal death and the selectivity of the neuronal population or brain structure involved in the lesion. Two main common forms of cell death that have been described in neurons as in other vertebrate tissues i.e., necrosis and apoptosis. Necrosis is the result of cellular “accidents”, such as those occurring in tissues subjected to chemical trauma. The necrotizing cells swell, rupture and provoke an inflammatory response. Apoptosis, on the other hand, is dependent on the cell’s “decision” to commit suicide and die, and therefore is referred to as “programmed cell death” (PCD). The course of apoptotic death is characterized by a massive morphological change, including cell shrinkage, nuclear (chromosome) condensation and DNA degradation. Activation of PCD in an individual cell is based on its own internal metabolism, environment, developmental background and its genetic information. Such a situation occurs in most of the neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Huntington’s diseases and amyotrophic lateral sclerosis (ALS). In these pathological situations, specific neurons undergo apoptotic cell death characterized by DNA fragmentation, increased levels of pro-apoptotic genes and “apoptotic proteins” both, in human brain and in experimental models. It is of utmost importance to conclusively determine the mode of cell death in neurodegenerative diseases, because new “antiapoptotic” compounds may offer a means of protecting neurons from cell death and of slowing the rate of cell degeneration and illness progression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alexianu M.E., Mohamed A.H., Smith R.G., Colom L.V., Appel S.H. (1994) Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis. J Neurochem 63(6): 2365–2368
Anderson A.J., Su J.H., Cotman C.W. (1996) DNA damage and apoptosis in Alzheimer’s disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 16: 1710–1719
Anglande P, Vyas S, Javoy-Agid F (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease. Histol Histopathol 12: 25–31
Banati R.B., Daniel S.E., Blount S.B. (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson’s disease. Mov Disord 13: 221–227
Bredesen D.E. (1995) Neural apoptosis. Ann Neurol 38: 839–851
Brown R.H. Jr (1997) Amyotrophic lateral sclerosis. Insights from genetics. Arch Neurol 54(10): 1246–1250
Butterworth N.J., Williams L, Bullock J.Y., Love D.R., Faull R.L., Dragunow M (1998) Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington’s disease striatum. Neuroscience 87: 49–53
Clutton S (1997) The importance of oxidative stress in apoptosis. Br Med Bull 53: 662–668
Cohen O, Kohen R, Lavon E, Abramsky O, Steiner I (1996) Serum Cu/Zn superoxide dismutase activity is reduced in sporadic amyotrophic lateral sclerosis patients. J Neurol Sci 143(1–2): 118–120
de la Monte S.M., Sohn Y.K., Wands J.R. (1997) Correlates of p53- and Fas (CD95)mediated apoptosis in Alzheimer’s disease. J Neurol Sci 152: 73–83
de la Monte S.M., Sohn Y.K., Ganju N, Wands J.R. (1998) P53- and CD95-associated apoptosis in neurodegenerative diseases. Lab Invest 78: 401–411
DiFiglia M, Sapp E, Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277: 1990–1993
Dorandeu A, Wingertsmann L, Chretien F, Delisle M.B., Vital C, Parchi P, Montagna P, Lugaresi E, Ironside J.W., Budka H, Gambetti P, Gray F (1998) Neuronal apoptosis in fatal familial insomnia. Brain Pathol 8: 531–537
Dragunow M, Faull R.L., Lawlor P, Beilharz E.J., Singleton K, Walker E.B., Mee E (1995) In situ evidence for DNA fragmentation in Huntington’s disease striatum and Alzheimer’s disease temporal lobes. Neuroreport 6(7): 1053–1057
Dragunow M, Faull R.L., Lawlor P (1996) In-situ evidence for DNA fragmentation in Huntington’s disease striatum and Alzheimer’s disease temporal lobes. Neuroreprot 6: 1053–10577
Durham H.D., Roy J, Dong L, Figlewicz D.A. (1997) Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J Neuropathol Exp Neurol 56(5):523–530
Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F (1993) Neurotoxicity of a prion protein fragment. Nature 362(6420): 543–546
Forloni G, Bugiani O, Tagliavini F, Salmona M (1996) Apoptosis-mediated neurotoxicity induced by beta-amyloid and PrP fragments. Mol Chem Neuropathol 1–3: 163–171
Fraker PJ, King LE, Lill-Elghanian D, Telford WG (1995) Quantification of apoptotic events in pure and heterogeneous popUlations of cells using the flow cytometer. Meth Cell Biol 46: 57–76
Gavrieli Y, Sherman Y, Ben-Sasson S.A., (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119(3): 493–501
Ghadge G.D., Lee J.P., Bindokas V.P., Jordan J, Ma L, Miller R.J., Roos R.P. (1997) Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J Neurosci 17: 8756–8766
Giese A, Groschup M.H., Hess B, Kretzschmar H.A. (1995) Neuronal cell death in scrapieinfected mice is due to apoptosis. Brain Pathol 5: 213–221
Goldberg Y.P., Nicholson D.W., Rasper D.M., Kalchman M.A., Koide H.B., Graham R.K., Bromm M, Kazemi-Esfarjani P, Thornberry N.A., Vaillancourt J.P., Hayden M.R. (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet 13: 442–449
Gorman A.M., McGowan A, O’Neill C, Cotter T (1996) Oxidative stress and apoptosis in neurodegeneration. J Neurol Sci 139: S45–S52
Gorman A.M., Orrenius S, Ceccatelli S (1998) Apoptosis in neuronal cells: role of caspases. Neuroreport 9: R49–R55
Gurney M.E. (1997) Transgenic animal models of familial amyotrophic lateral sclerosis. J Neurol 244 [Suppl 2]: S15–S20
Hochman A, Sternin H, Gorodin S, Korsmeyer S, Ziv I, Melamed E, Offen D (1998) Enhanced oxidative stress and altered antioxidants in brains of Bcl-2-deficient mice. J Neurochem 71: 741–748
Hutchins J.B., Barger S.W. (1998) Why neurons die: cell death in the nervous system. Anat Rec 253: 79–90
Irwin I, DeLanney L.E., McNeill T, Chan P, Forno L.S., Murphy G.M. Jr, Di Monte D.A., Sandy M.S., Langston J.W. (1994) Aging and the nigrostriatal dopamine system: a nonhuman primate study. Neurodegeneration 3: 251–265
Kaal E.C., Joosten E.A., Bar P.R. (1997) Prevention of apoptotic motoneuron death in-vitro by neurotrophins and muscle extract. Neurochem Int 31: 193–201
Kingsbury A.E., Mardsen C.D., Foster O.J. (1998) DNA fragmentation in human substantia nigra: apoptosis or perimortem effect? Mov Disord 13(6): 877–884
Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605–608
Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y, Taniguchi T (1997) Changes of p53 in the brains of patients with Alzheimer’s disease. Biochem Biophys Res Commun 232: 418–421
Kizaki H, Ohnishi Y, Azuma Y, Mizuno Y, Ohsaka F (1993) 1-beta-D-arabinosylcytosine and 5-azacytidine induce internucleosomal DNA fragmentation and cell death in thymocytes. Immunopharmacology. 25: 19–27
Kosel S, Egensperger R, Eitzen V, Mehraein P, Graeber M.B. (1997) On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol (Berlin) 93: 105–108
Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S (1997) Bcl- 2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277: 559–562
Kretzschmar H.A., Giese A, Brown D.R., Herms J, Keller B, Schmidt B, Groschup M (1997) Cell death in prion disease. J Neural Transm [Suppl] 50: 191–210
Langston W.J. (1998) Epidemiology versus genetic in genetic in Parkinson’s disease progress in resolving an age-old debate. Ann Neurol 44: S58–S62
Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM (1995) Cell death in Alzheimer’s disease evaluated by DNA fragmentation in situ. Acta Neuropathol (Berl) 89(1): 35–41
Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein M.J., Jonnalagada S, Chemova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson K.D., Polymeropoulos M.H. (1998) The ubiquitin pathway in Parkinson’s disease. Nature 395: 451–452
Lo A.C., Houenou L.J., Oppenheim R.W. (1995) Apoptosis in the nervous system: morphological features, methods, pathology, and prevention. Arch Histol Cytol 58: 139–149
Lucassen P.J., Williams A, Chung W.C., Fraser H (1995) Detection of apoptosis in murine scrapie. Neurosci Lett 198: 185–188
Luo Y, Umegaki H, Wang X, Abe R, Roth G.S. (1998) Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem 273:3756–3764
MacGibbon G.A., Lawlor P.A., Sirimanne E.S., Walton M.R., Connor B, Young D, Williams C, Gluckman P, Faull R.L., Hughes P, Dragunow M (1997) Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer’s disease. Brain Res 750: 223–234
MacGibbon G.A., Lawlor P.A., Walton M, Sirimanne E, Faull R.L., Synek B, Mee E, Connor B, Dragunow M (1997) Expression of Fos, Jun, and Krox family proteins in Alzheimer’s disease. Exp Neurol 147: 316–332
Masliah E, Raber J, Alford M, Mallory M, Mattson M.P., Yang D, Wong D, Mucke L (1998) Amyloid protein precursor stimulates excitatory amino acid transport. Implications for roles in neuroprotection and pathogenesis. J Biol Chem 273(20): 12548–12554
McGeer P.L., Kawamata T, McGeer E.G. (1998) Localization and possible functions of presenilins in brain. Rev Neurosci 9: 1–15
Mochizuki H, Goto K, Mori H, Mizuno Y (1996) Histology detection of apoptosis in Parkinson’s disease. J Neurol Sci 137: 120–123
Mu X, He J, Anderson D.W., Trojanowski J.Q., Springer J.E. (1996) Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann Neurol 40(3): 379–386
Nicholas W.W. (1998) Genetic risk in Parkinson’s disease. Ann Neurol 44: S58–S62
Nishimoto I (1998) A new paradigm for neurotoxicity by FAD mutants of betaAPP: a signaling abnormality. Neurobiol Aging 19: S33–S38
Offen D, Ziv I, Gorodin S, Barzilai A, Malik Z, Melamed E (1995) Dopamine-induced programmed cell death in mouse thymocytes. Biochim Biophys Acta 1268: 171–177
Offen D, Ziv I, Sternin H, Melamed E, Hochman A (1996) Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson’s disease. Exp Neurol 41: 32–39
Offen D, Ziv I, Panet H, Wasserman L, Stein R, Melamed E, Barzilai A (1997a) Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2. Cell Mol Neurobiol 17: 289–304
Offen D, Ziv I, Barzilai A, Gorodin S, Glater E, Hochman A, Melamed E (1997b) Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson’s disease. Neurochem Int 31: 207–216
Offen D, Beart P.M., Cheung N.S., Pascoe C.J., Hochman A, Gorodin S, Melamed E, Bernard R, Bernard O (1998) Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and I-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc Natl Acad Sci USA 95: 5789–5794
Ookohchi T, Ito H, Serikawa T, Sato K (1997) Detection of apoptosis in the brain of the zitter rat with genetic spongiform encephalopathy. Biochem Mol Biol Int 41: 279–284
Orrell R.W., Habgood J.J., Gardiner I, King A.W., Bowe F.A., Hallewell R.A., Marklund S.L., Greenwood J, Lane R.J., deBelleroche J (1997) Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-1zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology 48: 746–751
Poirier J, Sevigny P (1998) Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer’s disease. J Neural Transm [Suppl] 53: 199–207
Polymeropoulos M.H., Lavedan C, Leroy E, Ide S.E., Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos E.S., Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G, Golbe L.I., Nussbaum R.L. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276: 2045–2047
Portera-Cailliau C, Hedreen J.C., Price D.L., Koliatsos V.E. (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 15: 3775–3787
Prusiner S.B. (1998) The prion diseases. Brain Pathol 8(3): 499–513
Rabizadeh S, Gralla E.B., Borchelt D.R., Gwinn R, Valentine J.S., Sisodia S, Wong P, Lee M, Hahn H, Bredesen D.E. (1995) Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an anti-apoptotic gene to a pro-apoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA 92(7): 3024–3028
Renbaum P, Levy-Lahad E (1998) Monogenic determinants of familial Alzheimer’s disease: presenilin-2 mutations. Cell Mol Life Sci 54: 910–919
Saudou F, Finkbeiner S, Devys D, Greenberg M.E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95: 55–66
Sendtner M, Dittrich F, Hughes R.A. (1994) Actions of CNTF and neurotrophins on degenerating motor neurons: preclinical studies and clinical implications. J Neurol Sci 124: 77–83
Simantov R, Blinder E, Ratovitski T, Tauber M, Gabbay M, Porat S (1996) Dopamineinduced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transporter. Neuroscience 74: 39–50
Simonian N.A., Coyle (1997) Oxidative stress in neurodegenerative disease Annu Pharmacol Toxicol 36: 83–106
Small G.W. (1998) The pathogenesis of Alzheimer’s disease. J Clin Psychiatry 59: S7–S14
Takai N, Nakanishi H, Tanabe K, Nishioku T, Sugiyama T, Fujiwara M, Yamamoto K (1998) Involvement of caspase-like pin apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine. J Neurosci Res 54: 214–222
Tatton N.A., Maclean-Fraser A, Tatton W.G., Perl D.P., Olanow C.W. (1998) A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson’s disease. Ann Neurol 44: S142–S148
Tews DS, Goebel H.H., Meinck H.M. (1997) DNA-fragmentation and apoptosis-related proteins of muscle cells in motor neuron disorders. Acta Neurol Scand 96: 380–386
Thomas L.B., Gates D.J., Richfield E.K., O’Brien T.F., Schweitzer JB, Steindler D.A. (1995) DNA end labeling (TUNEL) in Huntington’s disease and other neuropathological conditions. Exp Neurol 133: 265–272
Troost D, Aten J, Morsink F, de-Jong J.M. (1995) Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol Appl Neurobiol 21: 498–504
Vechio J.D., Bruijn L.I., Xu Z, Brown R.H. Jr, Cleveland D.W. (1996) Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis. Ann Neurol 40(4): 603–610
Wellington C.L., Brinkman R.R., O’Kusky JR, Hayden M.R. (1997) Toward understanding the molecular pathology of Huntington’s disease. Brain Pathol 7: 979–1002
Wellington C.L., Ellerby L.M., Hackam A.S., Margolis R.L., Trifiro M.A., Singaraja R, McCutcheon K, Salvesen G.S., Propp S.S., Bromm M, Rowland K.J., Zhang T, Rasper D, Roy S, Thornberry N, Pinsky L, Kakizuka A, Ross C.A., Nicholson D.W., Bredesen D.E., Hayden M.R. (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 273: 9158–9167
Wiedau-Pazos M, Goto J.J., Rabizadeh S, Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., Bredesen D.E. (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271: 515–518
Williams A, Lucassen P.J., Ritchie D, Bruce M (1997) PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol 144(2): 433–438
Wyllie A.H., Kerr J.F.R., Currie A.R. (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251–306
Yang F, Sun X, Beech W, Teter B, Wu S, Sigel J, Vinters H.V., Frautschy S.A., Cole G.M. (1998a) Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer’s disease. Am J Pathol 152: 379–389
Yang L, Matthews R.T., Schulz J.B., Klockgether T, Liao A.W., Martinou J.C., Penney JB Jr, Hyman B.T., Beal M.F. (1998b) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing bcl-2. J Neurosci 18: 8145–8152
Yoshiyama Y, Yamada T, Asanuma K, Asahi T (1994) Apoptosis related antigen, Le(Y) and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 88: 207–211
Zhang J, Price J.O., Graham D.G., Montine T.J. (1998) Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures.Biochem Biophys Res Commun 248: 812–816
Ziv I, Melamed E, Nardi N, Luria D, Achiron A, Offen D, Barzilai A (1994) Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons-a possible novel pathogenic mechanism in Parkinson’s disease. Neurosci Lett 170: 136–140
Ziv I, Barzilai A, Offen D, Nardi N, Melamed E (1997) Nigrostriatal neuronal death in Parkinson’s disease: a passive or an active genetically-controlled process? J Neural Transm [Suppl] 49: S69–S76
Ziv I, Offen D, Barzilai A, Haviv R, Stein R, Zilkha-Falb Z.R., Shirvan A, Melamed E (1997) Modulation of control mechanisms of dopamine-induced apoptosis-a future approach to the treatment of Parkinson’s disease? J Neural Transm [Suppl] 49: S195–S202
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Wien
About this paper
Cite this paper
Offen, D., Elkon, H., Melamed, E. (2000). Apoptosis as a general cell death pathway in neurodegenerative diseases. In: Mizuno, Y., Calne, D.B., Horowski, R., Poewe, W., Riederer, P., Youdim, M.B.H. (eds) Advances in Research on Neurodegeneration. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6284-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6284-2_13
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7246-9
Online ISBN: 978-3-7091-6284-2
eBook Packages: Springer Book Archive